ClinicalTrials.Veeva

Menu

Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank (BIO-F)

G

Gustave Roussy

Status

Unknown

Conditions

Paediatric Malignancies

Treatments

Procedure: blood samples
Procedure: saliva samples

Study type

Observational

Funder types

Other

Identifiers

NCT02666625
2010-A00555-34
2010/1623 (Other Identifier)

Details and patient eligibility

About

The constitution of a biological samples bank, attached to epidemiological studies Cohort F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic variants that can modulate the iatrogenic risks of these treatments. The main objective is to provide a biological samples bank to consider, besides the carcinogenic risks, the risk of other iatrogenic diseases in these children, in particular cardiac, cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and in some cases, fatal. Their impact, however, is poorly estimated as occurring in adulthood, they are rarely made in relation to the treatment received in childhood. The overall project is expected to eventually better define the iatrogenic effects prevention strategies for cancer treatment.

Enrollment

6,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients treated for a first cancer in childhood
  • Adult patients
  • Signed informed consent
  • Patient insured or enjoying a social security scheme

Exclusion criteria

  • Minor patients
  • Under legal protection measure patients
  • Refusal of consent

Trial design

6,000 participants in 1 patient group

Patients treated for cancer in childhood
Treatment:
Procedure: blood samples
Procedure: saliva samples

Trial contacts and locations

1

Loading...

Central trial contact

Carole Rubino, MD; Nadia Haddy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems